Aka, quantom, pre.....
...The simple reality is, in these current times, common shareholders get screwed royal investing in "new science".
GTCB and RPRX are two fine examples.
... We all know the real score...FDA, BP, Politics and poor management.
RPRX has three positives...the science, the CEO,(so far anyways) and with a small OS,,,We still have a chance.
GTCB has only one positive, the science.
...As to a "thousand shades of grey"...RPRX and its common are at the mercy of a hedge fund or two.
Market Data 
Markets 
AI
